Overview

The Effect of Fasudil on Vascular Function in Humans

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate how the rho kinase inhibitor, fasudil, affects vascular function in patients with atherosclerosis and hyperlipidemia.
Phase:
Phase 2
Details
Lead Sponsor:
Brigham and Women's Hospital
Treatments:
Fasudil